XX% you, we revenue EBITDA adjusted and evening reported our Thank were from growth, to adjusted afternoon, quarter growth share and growth of execution earnings second benefited you. business robust results timing We that This drove lines expectations. first good of for favorable per organic and share year for strong a good the adjusted our to XX%. ahead XX% all Chase, of per of had We to earnings and of adjusted number in which to our confidence growth. us guidance and lower full of Year-to-date the reaffirm $X.XX, end increase guidance, or items half, gives the our mid-single-digit performance range the revenue $X.XX of a in EBITDA resulting outperformance.
momentum several Over to global our in demand clean we security, the and positive months, markets. last experience energy medical continue
the therapeutics and being pharmaceutical complemented the regulatory demand major utilities and to looking prioritize a in state and clarity, for federal of This complex clean power seeing as attack companies capacity radio add governments industry. nuclear are consumers ranges from cancers. first reliable by funding are line alternative to to and as grid We power nuclear private energy from investments
our a and development and cycle our and unique life our licenses partner BWXT. of services we across are engineering customers, substantial life capable goals in realize maximize to well position segments us from early markets depth, various their supplier components open concept to core, utilization BWX for project cycles. infrastructure differentiated At industry of visibility of customers everything lifespan provides into and help their technical potential nuclear design across the through and serve This opportunities we us assets. ultimately providing manufacturing the long-term the stages to and
the market our Now and standpoint, well turning our continued of ramp operations From had and to driven naval XX% solid growth, ahead nuclear in in an microreactor results performed propulsion growth business. discussion well on quarter newer EBITDA the a outlook. a as as special and materials quarter. solid projects expectations XX% propulsion by segment of volumes operational revenue adjusted with Government and both our naval business
wall aircraft our with XXXX and XXXX, ordering As finding work and we lower last for keep are tempo of carrier plants seeking quarter, discussed loads. associated with the level potentially be through but operating ways the us the Ford will class to detail in at at least we
the and businesses of our headwinds to throughout positioning. effectiveness to our We remain to ensure competitive schedules next we organization time, expect pricing initiatives capacity we on driving mitigate continue agreement and for sufficient process invest finalize these At intensely improve to coming and the improvements focused equipment in to operational execution months. the same in our program
Ambarella, transition Pantex quality capacity. investments improve in these Texas. significant the plant For can on successful margin the create fuel award and such line to we operations, contract and newer Also growing demand, example, within services plant about quarter, in a product modest our headwinds, make to modernization in facility second but and are very we process investments quick we near-term government support engaged in production excited and to
this important a supervise BWXT is XX, our XX-year in July NSAA further solidifying contract, of As side a leadership space. that under will leading venture the joint
are business lay in land Energy on reactors defense-related micro space we Authority Reactor of and largely micro recon the program. And Pay line, under state the work the viability deploying to banner in projects, well. continue Department assess that leveraging the of reactors Energy's progressing the Wyoming to our In development with funded our commercial sector, work Advanced
the In power unit generating of of megawatts strong a for experience position we have defense selected, partners We leading the related component our a innovation in XX U.S. fuel put us with Army microreactor an manufacturing Tala this for facilities matter, Army in and and of our to capable early June, X posted bases. of believe opportunity. and existential team remarkable
in trends Materials the as growth mid-single-digit naval propulsion favorable. growth government for segment segment's EBITDA revenue is medium-term demand remain modest long-term operations in Special and enhanced outlook our adjusted nuclear in real and growth reactors, in We are Services. business Overall, by micro our confident Technical
grew XX%. with Demand blossoming and is Turning the industry, nuclear and commercial organically to Revenue XX% Commercial interest Operations. for EBITDA segment in utilities government adjusted buyers. power grew from
for pressure During to Arlington the we BWRX-XXX Generation site. notice full reactor quarter, reactor of the Ontario Hitachi's small with vessel Power GE manufacturer the modular received proceed project at
reference first for the developers assessing of the point build-out meaningful MRs. for Western Hemisphere, strategically in SMR this a project BWXT and project also an the power is As is important plant
Dominion a in million Power SMR partner issuing Energy This of North merchant development. We technology and America. that with as equipment growing Additionally, the the MR to up at it a by Anna North largest in capabilities a deep and with to RFP followed provide assembly to facility in an interest of $XXX design modular nuclear expressing was manufacturer the build reactors. nuclear list Virginia. an in spur small funding market to SMR Dominion June, of Station joins international announced domestic the will utilities faced Department building Energy
higher In had driven projects service bring Cannon outage life market, generally solid quarter strong margins. the toward field growth ongoing we that and extension by a weighted projects slightly
will of this earnings life work that Ontario and units through bookings the on early be starting X, Pickering part extension Generation's over life the Power are of cycle a of project. segment's next XX-year We which X
is of in continue portfolio on our approximately making be we in XXXX existing our progress Turning are executing year expanding first cancer diagnostics key our lines in to to I with BWXT the of tracking Medical. growth. and growing pleased expectation therapeutics. XX% and with in Revenue half line the product full
Specifically, last used treatment of for the multiple extended over leading cancer. trust position has its being of therapeutic clinical isotopes high-quality months, actinium-XXX, over the forms couple of a XX BWXT in in commercial
drug In June, a ingredient. master file we the submitted actinium-XXX our FDA pharmaceutical or with
this medical isotope. to the now This our important an trials with drugs only active pharmaceutical file drug product to companies clinical are enables company prepared commercial We file for applications. they reference are new advance drug as master vitally through
announced North accelerator with production into to this design, to waste we the our a addition focused in target initially starter over This and and time, current produce the will strategy North could of a we July, utilized Star's sourcing evolve actinium our suite purification Vancouver. with Additionally, the In irradiation, we that constructing to But and develop radium-XXX and with to be full partnership Star, BWXT on are actinium-XXX. operations partnership in processing provide of Electronic radium-XXX including services, in second source ecosystem instance, will targets. whereby services in irradiation gets manufacture shovel serve a difficult pick processing highlights which that through irradiated stream Star, North material management.
we Tech-XX commercialization Diagnostics, In strategy. advance to continue our and development
pending produced have approval product support successfully the date our work at we and to for the see FDA generators We customer test the as previously continue with FDA more and outlined becomes visible. pace clear
customers enable We marketing volumes commitments and have of to supply become when to our agreements they and with been actively testing significant product spot samples available.
launch a XXXX and rate gradual increases smooth of a the into planned XXXX volumes beyond. to entrant have ensure full annual methodical throughout a contracted We in market and with product run
technetium-XXm of phase, larger Dr. development Finally, his operational driving having it and the made to a and microreactors, Medical BWXT that commercial in will product a the as my product XXXX business of Jonathan are foundations and growth and EBITDA. strides strategy of on doubling the including Chief therapeutic direct Vittorio year operational other positive role executive his on others. Medical charge most nearly BWXT BWXT product to XX-year-plus this to Development Certain the remarkable new industry has among will Bracco establish sales announce He talent generator alongside portfolio, focus portfolio, run commercial from the medicine special to with and now staff to growing developing business. exciting I and career approval regulatory lines. expertise month. should to Please materials a and He Pufa we development fuels, the product adding advanced in and join Medtronic, pointed return at as Amersham, brings resume in spent maintaining Officer, a nuclear deep in BWXT Vittorio more this balance and
quarter, position nuclear segments. a and capture and these we overweight exciting business growing had in of we and strong to Overall, market BWXT continue share to
over steadily There year-to-date desire leads signals per processing compelling will has BWXT us from the see address and workforce that, and infrastructure use I credentialed is nuclear services and our firm benefit like many increasing. Our unique we to capabilities range. our and Robb. from opportunities customers to XXXX world-class us turn are private enables performance by to guidance experienced the government adjusted nuclear to share demand challenges earnings our narrow and backed their manufacturing call and that to solutions ahead.
With highly now their
